Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus (DESTINY)

B

Besins Healthcare

Status

Completed

Conditions

Hypogonadism
T2DM (Type 2 Diabetes Mellitus)

Treatments

Diagnostic Test: Laboratory tests

Study type

Observational

Funder types

Industry

Identifiers

NCT03437109
BH-DM-11-2017

Details and patient eligibility

About

The purpose of the study is to get data of prevalence of testosterone deficiency in patient with T2DM in Russian Federation

Full description

Clinical and Epidemiological Characteristics and Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus Under Routine Clinical Practice (DESTINY)

Enrollment

554 patients

Sex

Male

Ages

45 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male 45-60 years old
  • Diagnosis of T2DM according to approved standards
  • Signed Informed Consent Form

Exclusion criteria

  • Prepubertal hypogonadism of any genesis;
  • Sexual and developmental disorders;
  • Absence of at least one of the testicles;
  • Cryptorchidism, including in the anamnesis;
  • Injuries and / or surgical interventions on the genitals with loss of at least one of the testicles;
  • Established diagnosis of panhypopituitarism in accordance with current recommendations / standards;
  • Androgen therapy, administered at the time of the study or in the anamnesis;
  • Admission of anabolic steroids;
  • Alcoholism or drug addiction;
  • Insolvency.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems